TABLE 1.
RNFL reduction on OCT |
||||||
Author, year | No. patients | Age (yr)/sex | Sex | OTL etiology | Ipsilateral eye | Contralateral eye |
Tatsumi et al. (10) | 1 | 20 | F | Trauma | INF | TEMP, NAS |
Monteiro and Hokazone (22) | 2 | 23 | M | 1 Trauma | SUP, INF | TEMP, NAS |
29 | 1 Macroadenoma | |||||
Hsu et al. (9) | 8 | 37.7 ± 12.8 | 4 F | 7 Trauma | SUP, INF, TEMP | TEMP, NAS, SUP, INF |
(mean) | 4 M | 1 PVL | ||||
Kanamori et al. (23) | 4 | 25.2 ± 4.4 | 2 F | 1 Glioma | SUP, INF | TEMP, NAS |
(mean) | 2 M | 1 Metastasis | ||||
1 AVM | ||||||
1 Trauma | ||||||
Gabilondo et al. (4) | 1 | F | MS | SUP, INF | NAS | |
Lloyd-Smith et al. (11) | 1 | 49 | M | NA | SUP, INF, TEMP | TEMP, NAS |
Goto et al. (24) | 8 | 40.4 ± 14.5 (mean) | 1 F | Trauma | ||
7 M | ||||||
Goto et al. (8) | 1 | 25 | M | Trauma | SUP, INF | TEMP, NAS |
Present study, 2021 | 6 | 20.67 ± 18.47 (mean) | 2 F | 1 Trauma | SUP, INF | TEMP, NAS |
4 M | 2 Astrocytoma | |||||
3 Glioma | ||||||
All studies | 32 | 32.73 ± 15.41 (mean) | 11 F | 20 Trauma | ||
21 M | 8 SOL | |||||
1 AVM | ||||||
1 PVL | ||||||
1 MS | ||||||
1 unavailable |
INF, inferior; NAS, nasal; SUP, superior; TEMP, temporal; AVM, arteriovenous malformation; MS, multiple sclerosis; PVL, periventricular leukomalacia.